Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Assessment on Current Outcomes of Peritoneal Dialysis in Korea (PDKOREA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02573675
Recruitment Status : Unknown
Verified October 2015 by Ewha Womans University.
Recruitment status was:  Not yet recruiting
First Posted : October 12, 2015
Last Update Posted : October 12, 2015
Sponsor:
Information provided by (Responsible Party):
Ewha Womans University

Brief Summary:
In this study, the recent trends in outcomes according to the dialysis modality in Korea since 2009, the effect of the use of peritoneal dialysis solutions containing icodextrin or high-glucose on various outcomes, the usefulness of 'PD first strategy', and the economic burden according to the dialysis modality will be investigated retrospectively using the Korean Health Insurance Review and Assessment Service (HIRA) database.

Condition or disease
Kidney Failure, Chronic

Detailed Description:

This study is designed as an observational and retrospective cohort study, thus there will be no intervention or specified prescription.

For the comparison of outcomes according to dialysis modality, we will adopt an intention-to-treat analysis, and consider the dialysis modality at day 90 to be the initial dialysis modality. However, the investigators will also regard the dialysis modality at day 30 as the initial dialysis modality in order to evaluate and compare earlier mortality.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: An Assessment on Current Outcomes of Peritoneal Dialysis in Korea
Study Start Date : November 2015
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : October 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis




Primary Outcome Measures :
  1. Survival rate according to dialysis modality [ Time Frame: up to 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All incident dialysis patients who started chronic dialysis therapy between January 1, 2009 and December 31, 2014 in Korea
Criteria

Inclusion Criteria:

  • Patients who started dialysis during the study period and remained on the dialysis therapy for at least 90 days

Exclusion Criteria:

  • Patients who were younger than 18 years of age
  • Patients who survived for less than 90 days from the date of dialysis initiation
Publications:
Layout table for additonal information
Responsible Party: Ewha Womans University
ClinicalTrials.gov Identifier: NCT02573675    
Other Study ID Numbers: PDKOREA-1
First Posted: October 12, 2015    Key Record Dates
Last Update Posted: October 12, 2015
Last Verified: October 2015
Keywords provided by Ewha Womans University:
hemodialysis
peritoneal dialysis
Additional relevant MeSH terms:
Layout table for MeSH terms
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic